In March 2025, the company declared new plans for a direct-to-customer presenting of its Wegovy weight loss drug. The company set up a new pharmacy, referred to as NovoCare, which might cost clients $499 a month for entry to the drug, fewer than 50 percent the price of the drug through other pha